日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer

一项随机II期研究比较了帕博利珠单抗联合放化疗同步给药与序贯给药治疗局部晚期头颈癌的疗效

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-01580
Zandberg, Dan P; Vujanovic, Lazar; Clump, David A; Isett, Brian P; Wang, Hong; Sica, Gabriel; Bao, Riyue; Li, Housayin; Ohr, James; Skinner, Heath D; Seethala, Raja R; Chiosea, Simion I; Ferris, Robert L; Bauman, Julie E
肿瘤
肿瘤免疫
头颈癌
发表日期：2025
文献求助 收藏

Comparative in vivo toxicology of ATR inhibitors ceralasertib, elimusertib, and berzosertib alone and in combination with ionizing radiation

ATR抑制剂ceralasertib、elimusertib和berzosertib单独使用及与电离辐射联合使用时的体内毒理学比较

期刊:Toxicology and Applied Pharmacology
影响因子:3.4
doi:10.1016/j.taap.2025.117375
Deppas, Joshua J; Kiesel, Brian F; Guo, Jianxia; Rigatti, Lora H; Latoche, Joseph D; Green, Anthony; Knizner, Paul; Clump, D Andy; Pandya, Pinakin; Vendetti, Frank P; Bakkenist, Christopher J; Beumer, Jan H
ATR
发表日期：2025
文献求助 收藏

Artificial Intelligence and Machine Learning in Sexual Health and Dysfunction Across the Cancer Care Continuum: A Systematic Review

人工智能和机器学习在癌症治疗全程性健康与性功能障碍中的应用：系统性综述

期刊:Cancers
影响因子:
doi:10.3390/cancers17183025
Salama, Vivian; Godinich, Brandon M; Lilly, Peyton M; Pifer, Phillip M; Duckworth, Adrienne L; Hall, Samantha J; Alabboodi, Maher; Siochi, R Alfredo; Clump, David A; Emadi, Ashkan
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary-a pilot study

人乳头瘤病毒循环肿瘤DNA：一种用于诊断原发灶不明的鳞状细胞癌的工具——一项初步研究

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1376595
Kais, Amani; Santiago, Stell Patadji; Han, Peng Cheng; Clump, David A; Stokes, William A; Fancy, Tanya; Cui, Ruifeng; Martin, Elizabeth; Turner, Meghan T
肿瘤
肿瘤免疫
微生物学
Human
细胞生物学
发表日期：2024
文献求助 收藏

Non-linear IV pharmacokinetics of the ATR inhibitor berzosertib (M6620) in mice

ATR 抑制剂 berzosertib (M6620) 在小鼠体内的非线性 IV 药代动力学

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.7
doi:10.1007/s00280-024-04675-3
Joshua J Deppas, Brian F Kiesel, Jianxia Guo, Robert A Parise, D Andy Clump, David Z D'Argenio, Christopher J Bakkenist, Jan H Beumer
信号转导
发表日期：2024
文献求助 收藏

Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery

NRG Oncology RTOG 0436 研究中的患者报告结局 (PRO)：一项评估在未接受手术治疗的食管癌患者中，西妥昔单抗联合紫杉醇、顺铂和放疗疗效的 III 期临床试验。

期刊:Quality of Life Research
影响因子:2.7
doi:10.1007/s11136-024-03736-7
Kachnic, Lisa A; Winter, Kathryn; Suntharalingam, Mohan; Ilson, David; Konski, André; Lloyd, Shane; McAvoy, Sarah A; Lad, Thomas; Olowokure, Olugbenga Gbenga; Samson, Pamela; Gore, Elizabeth M; Meyer, Joshua E; Videtic, Gregory M M; Clump, David A; Raben, Adam; Kayaleh, Omar; Barker, Jerry Jr; Haddock, Michael G; Hopkins, Judith O; Bruner, Deborah W
食管癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial

放射治疗联合紫杉醇加帕唑帕尼或安慰剂治疗间变性甲状腺癌（NRG/RTOG 0912）：一项随机、双盲、安慰剂对照、多中心 II 期试验

期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(22)00763-X
Sherman, Eric J; Harris, Jonathan; Bible, Keith C; Xia, Ping; Ghossein, Ronald A; Chung, Christine H; Riaz, Nadeem; Gunn, G Brandon; Foote, Robert L; Yom, Sue S; Wong, Stuart J; Koyfman, Shlomo A; Dzeda, Michael F; Clump, David A; Khan, Saad A; Shah, Manisha H; Redmond, Kevin; Torres-Saavedra, Pedro A; Le, Quynh-Thu; Lee, Nancy Y
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏

Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504

纳武利尤单抗联合放化疗治疗中高危局部晚期头颈部鳞状细胞癌的安全性：RTOG基金会3504

期刊:International Journal of Radiation Oncology Biology Physics
影响因子:6.5
doi:10.1016/j.ijrobp.2022.10.008
Gillison, Maura L; Ferris, Robert L; Harris, Jonathan; Colevas, A Dimitrios; Mell, Loren K; Kong, Christina; Jordan, Richard C; Moore, Kevin L; Truong, Minh-Tam; Kirsch, Claudia; Chakravarti, Arnab; Blakaj, Dukagjin M; Clump, David A; Ohr, James P; Deeken, John F; Gensheimer, Michael F; Saba, Nabil F; Dorth, Jennifer A; Rosenthal, David I; Leidner, Rom S; Kimple, Randall J; Machtay, Mitchell; Curran, Walter J Jr; Torres-Saavedra, Pedro; Le, Quynh Thu
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy

ATR 抑制剂 AZD6738 的给药方案可以增强或消除放射治疗的抗肿瘤免疫反应

期刊:JCI Insight
影响因子:6.3
doi:10.1172/jci.insight.165615
Frank P Vendetti, Pinakin Pandya, David A Clump, Sandra Schamus-Haynes, Meysam Tavakoli, Maria diMayorca, Naveed M Islam, Jina Chang, Greg M Delgoffe, Jan H Beumer, Christopher J Bakkenist
免疫
肿瘤
发表日期：2023
文献求助 收藏

Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network

大型综合医疗网络中与导管原位癌 (DCIS) 治疗模式和患者报告结局相关的因素

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-022-06831-w
Kim, Hayeon; Wang, Hong; Demanelis, Kathryn; Clump, David A; Vargo, John A; Keller, Andrew; Diego, Mia; Gorantla, Vikram; Smith, Kenneth J; Rosenzweig, Margaret Q
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏